Display options
Share it on

Middle East J Dig Dis. 2011 Mar;3(1):50-5.

Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome.

Middle East journal of digestive diseases

H Nobakht, F Zamani, H Ajdarkosh, Z Mohamadzadeh, Sm Fereshtehnejad, M Nassaji

Affiliations

  1. Assistant Professor of Gastroenterology and Hepatology, Fatemieh hospital, Semnan University of Medical Sciences, Semnan, Iran.
  2. Associate Professor of Gastroenterology and Hepatology, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
  3. Assistant Professor of Gastroenterology and Hepatology, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
  4. Research Fellow, Imam-Khomeini General Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
  5. Research Fellow, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
  6. Assistant Professor of Infectious Diseases, Fatemieh hospital, Semnan University of Medical Sciences, Semnan, Iran.

PMID: 25197532 PMCID: PMC4154930

Abstract

BACKGROUND Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by sporadic, paroxysmal attacks of fever and serosal inflammation. Although the disease usually begins before the age of 20 years, we aimed to evaluate the demography, clinical features and treatment outcome of familial Mediterranean fever in Iranian adult patients above 20 years old. METHODS In this cross-sectional study, adult patients (first attack at the age of >20 years) with a diagnosis of FMF who referred to the gastroenterology and rheumatology Clinics of Ardebil University of Medical Science (situated in north west of Iran) over the period of 2004-2009 were enrolled. FMF diagnosis was based on clinical criteria. RESULTS Forty four FMF patients (30 male and 14 female) with the mean [± Standard Deviation (SD)] age of first attack of 29 ± 7.8 years were enrolled. Abdominal pain (95.5%) and fever (91%) were the most common clinical findings. All of the patients had satisfactorily responded to therapy. Response was complete in 76.7% and partial in 23.3% of the patients. There was no clinical or laboratory evidence of amyloidosis at the time of diagnosis or during follow-up. CONCLUSION Our findings demonstrated that adult-onset FMF in Iran has different characteristics (more common in males, lesser prevalence of arthritis and erysipelas-like erythema, less delay in diagnosis) and treatment outcome (favorable response even to low-dose colchicine) in comparison with the previous data on early onset patients.

Keywords: Adult onset; Clinical features; Familial Mediterranean fever; Treatment

References

  1. Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):199-213 - PubMed
  2. Dig Liver Dis. 2000 Aug-Sep;32(6):504-9 - PubMed
  3. Rheumatol Int. 2010 May;30(7):911-5 - PubMed
  4. Rheumatol Int. 2006 Apr;26(6):489-96 - PubMed
  5. Rheumatol Int. 2009 Sep;29(11):1279-85 - PubMed
  6. Turk J Pediatr. 2008 Jan-Feb;50(1):40-4 - PubMed
  7. J Rheumatol. 2009 Aug;36(8):1671-6 - PubMed
  8. J Rheumatol. 2006 Jun;33(6):1089-92 - PubMed
  9. Rheumatology (Oxford). 2009 Jul;48(7):840-2 - PubMed
  10. Lancet. 1998 Feb 28;351(9103):659-64 - PubMed
  11. Arthritis Rheum. 1997 Oct;40(10):1879-85 - PubMed
  12. Arthritis Rheum. 2009 Oct 15;61(10):1447-53 - PubMed
  13. Medicine (Baltimore). 2005 Jan;84(1):1-11 - PubMed
  14. Joint Bone Spine. 2009 May;76(3):227-33 - PubMed
  15. Semin Arthritis Rheum. 2008 Apr;37(5):334-8 - PubMed
  16. Am J Med Genet. 1999 Nov 5;87(1):30-5 - PubMed
  17. Pediatr Nephrol. 2003 Sep;18(9):853-9 - PubMed
  18. Int J Clin Pract. 2005 Feb;59(2):202-5 - PubMed
  19. Mol Biol Rep. 2010 Jan;37(1):1-5 - PubMed
  20. Clin Exp Rheumatol. 1994 May-Jun;12(3):347-8 - PubMed
  21. Am J Med. 1967 Aug;43(2):227-53 - PubMed

Publication Types